iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionInstitute for Wealth Management, LLC.
Latest Disclosed Ownership3,303 shares
Latest Disclosed Value $ 557,694
Institute for Wealth Management, LLC. reports 6.76% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 14, 2026 - Institute for Wealth Management, LLC. filed a 13F-HR form disclosing ownership of 3,303 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $557,694 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 3,094 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 6.76% during the quarter. The current value of the position is $432,858 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,303 209 6.76 558 6.70 0.0594
2026-01-27 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,094 -60 -1.90 522 14.73 0.0553
2025-10-17 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,154 -138 -4.19 455 9.38 0.0474
2025-07-18 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,292 -85 -2.52 416 -3.48 0.0464
2025-04-21 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,377 0 0.00 432 -3.36 0.0554
2025-01-23 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,377 0 0.00 446 -9.16 0.0559
2024-11-12 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,377 -220 -6.12 492 -0.41 0.0620
2024-07-25 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,597 103 2.95 494 2.92 0.0662
2024-04-30 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,494 0 0.00 479 1.05 0.0618
2024-01-31 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,494 -35 -0.99 475 9.98 0.0770
2023-10-13 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,529 80 2.32 432 -1.37 0.0778
2023-07-25 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,449 0 0.00 438 -1.80 0.0739
2023-04-20 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,449 0 0.00 445 -1.55 0.0851
2023-02-02 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 3,449 0 0.00 453 12.16 0.0952
2022-10-18 2022-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 3,449 491 16.60 403 15.80 0.0904
2022-07-25 2022-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,958 -13 -0.44 348 -10.08 0.0683
2022-04-29 2022-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,971 250 9.19 387 -6.75 0.0626
2022-01-21 2021-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 2,721 -20 -0.73 415 -6.32 0.0676
2021-11-15 2021-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,741 -112 -3.93 443 -5.14 0.0778
2021-07-21 2021-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 2,853 112 4.09 467 13.08 0.0820
2021-05-04 2021-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,741 26 0.96 413 0.49 0.0785
2021-02-01 2020-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,715 35 1.31 411 13.22 0.0817
2020-11-03 2020-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,680 184 7.37 363 6.45 0.0829
2020-07-30 2020-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,496 0 0.00 341 26.77 0.0835
2020-04-29 2020-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,496 170 7.31 269 -3.93 0.0829
2020-02-27 2019-12-31 13F/A-1 ISHARES TR NASDAQ BIOTECH 464287556 2,326 9 0.39 280 21.21 0.0632
2020-01-27 2019-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 280 -2,037 280 65,021.6197
2019-10-28 2019-09-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,317 0 0.00 231 -8.70 0.0582
2019-08-02 2019-06-30 13F ISHARES TR NASDAQ BIOTECH 464287556 2,317 75 3.35 253 0.80 0.0560
2019-05-15 2019-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,242 2,242 251 0.0546
2018-05-15 2018-03-31 13F ISHARES TR NASDAQ BIOTECH 464287556 0 -2,879 -100.00 0 -100.00
2018-02-12 2017-12-31 13F ISHARES TR NASDAQ BIOTECH 464287556 2,879 2,879 305 0.0704
2017-11-14 2017-09-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 0 -833 -100.00 0 -100.00
2017-08-14 2017-06-30 13F ISHARES TR NASDQ BIOTEC ETF 464287556 833 833 257 0.0707
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.